Á lódáil...
MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
BACKGROUND AND PURPOSE—: This study aimed to assess the efficacy of modafinil, a wakefulness-promoting agent in alleviating post-stroke fatigue ≥3 months after stroke. We hypothesized that 200 mg of modafinil daily for 6 weeks would result in reduced symptoms of fatigue compared with placebo. METHOD...
Na minha lista:
Foilsithe in: | Stroke |
---|---|
Main Authors: | , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Lippincott Williams & Wilkins
2017
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5404401/ https://ncbi.nlm.nih.gov/pubmed/28404841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.016293 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|